🔎 Trials Near Me

Hjem › Metastatisk kreft › California › Sacramento

Kliniske studier for Metastatisk kreft i Sacramento, CA

16 studier for Metastatisk kreft søker deltakere på steder i og rundt Sacramento (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RekruttererFase 2
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi unna
Alle aldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

RekruttererFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05372614

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

RekruttererFase 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
  • University of California, Davis Medical Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07222800

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

RekruttererFase 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
Alder 12 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RekruttererFase 3
  • University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RekruttererFase 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

RekruttererFase 1
  • The University of California Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06389123

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

RekruttererFase 1
  • University of California (UC) Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

RekruttererFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT07189195

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

RekruttererFase 3
  • Sutter Institute for Medical Research, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 25. jun. 2026 · NCT06216301

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

RekruttererFase 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

RekruttererFase 1
  • University of California Davis, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jun. 2026 · NCT06917079

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

RekruttererFase 1/2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Alder 12 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT05384626

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

RekruttererFase 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT06521554

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

RekruttererFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT06778863

Metastatisk kreft-studier i andre byer

Andre studier i Sacramento

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.